Close Menu

computational biology

NEW YORK (GenomeWeb News) – Biopharmaceutical firm Berg and the US Department of Defense today announced an agreement to discover biomarkers for prostate cancer and to develop more effective treatments for the disease.

NEW YORK (GenomeWeb News) – Cancer genomics firm Foundation Medicine has filed to go public, with a target goal of raising as much as $86.3 million.

NEW YORK (GenomeWeb News) – German startup biotech firm Blackfield today announced a collaboration with AstraZeneca in support of one of the biopharmaceutical firm's oncology drug development programs.

NEW YORK (GenomeWeb News) – Stanford University has launched a new genomics research center that will foster collaboration across its seven schools and harness new computational technologies, it said today.

NEW YORK (GenomeWeb News) – Retrotransposon movement in somatic cells may introduce insertions in the genome that contribute to tumorigenesis in certain cancer types, according to a study in the early, online edition of Science today by members of the Cancer Genome Atlas Research Network

NEW YORK (GenomeWeb News) – Berg Pharma will use its Integrative Biology platform to identify drug targets and biomarkers in clinical samples from the Parkinson's Institute of Sunnyvale, Calif., under a partnership announced today.

NEW YORK (GenomeWeb News) – Genome Canada and the Canadian Institute of Health Research will award C$6.3 million (US$6.1 million) to research projects under its 2012 Bioinformatics and Computational Biology Competition to develop new tools to deal with the large volumes of data being generated fr

Spain's Centre for Genomic Regulation and French pharmaceutical firm Sanofi have launched a partnership to pursue collaborative research projects in medical genetics, epigenetics, and computational biology that will focus on studies of genetic and rare diseases.

By a GenomeWeb staff reporter
NEW YORK (GenomeWeb News) – Evogene today reported a 31 percent revenue spike for the third quarter ended Sept. 30.

By a GenomeWeb staff reporter
NEW YORK (GenomeWeb News) – Enhancer elements that regulate and bump up the expression of some genes can arise de novo in vertebrate genomes, a new study suggests.

Pages

At the Lancet, more than two dozen public health researchers condemn the conspiracy theories that have emerged surrounding the source of the COVID-19 outbreak.

The Washington Post reports that Philip Leder, who helped uncover how DNA codes for proteins and studied the role of genes in cancer, has died.

Researchers from Trinity College Dublin and the University of Pittsburgh look into how often de novo genes arise and how important they may be.

In Nucleic Acids Research this week: pipeline for genotyping Alu retrotransposon mobile element insertions, previously undocumented non-coding RNAs, and more.